Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
about
Aptamers: A promising chemical antibody for cancer therapyNucleic acid aptamers: an emerging frontier in cancer therapyAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateIdentification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2General cell-binding activity of intramolecular G-quadruplexes with parallel structureLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Specific capture and temperature-mediated release of cells in an aptamer-based microfluidic device.Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.Aptamer-targeted cell-specific RNA interferenceA U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery.Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyRecent developments in protein and cell-targeted aptamer selection and applicationsAptamers from cell-based selection for bioanalytical applicationsUse of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cellsCell-specific aptamer-mediated targeted drug deliveryAptamers: versatile probes for flow cytometry.Whole cell-SELEX aptamers for highly specific fluorescence molecular imaging of carcinomas in vivo.Aptamer technology for tracking cells' status & function.Ligand-Guided Selection of Target-Specific Aptamers: A Screening Technology for Identifying Specific Aptamers Against Cell-Surface Proteins.Ligand-guided selection of aptamers against T-cell Receptor-cluster of differentiation 3 (TCR-CD3) expressed on Jurkat.E6 cells.Facile Discovery of Cell-Surface Protein Targets of Cancer Cell Aptamers.PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemiaEvolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface AntigensIdentification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationIdentification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells.Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureusThe chemical biology of aptamers.CELL-SELEX: Novel perspectives of aptamer-based therapeutics.Aptamers and aptamer targeted delivery.Aptamers generated by Cell SELEX for biomarker discovery.Aptamer applications for targeted cancer therapy.Aptamers: turning the spotlight on cells.Intracellular delivery of RNA-based therapeutics using aptamers.Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.Escort aptamers: new tools for the targeted delivery of therapeutics into cells.Graphene and its derivatives for cell biotechnology.The application of aptamers in cancer research: an up-to-date review.Application of aptamers for targeted therapeutics.
P2860
Q26766832-96C4AE85-2BCA-422C-9656-C83D961DD368Q26849947-FEFF8A7D-ED24-4556-832E-ED3401E4EB88Q28066827-E67F75A3-342A-4ACE-9A24-3F9B9858111AQ28484118-5DCD3FF9-B25D-43EB-AE44-B6928D354BD2Q28487102-8D3B3F21-53D5-4BEE-B311-9016A5932A4AQ30366990-434C1B29-AC8A-49A0-8703-19011913188AQ30440489-4366F20C-2AF3-4B27-918A-56DF2C0DFB41Q33598723-CE879277-9DE6-4276-A909-7FA56AC8D83BQ33717239-856C8113-BEF3-4B89-93BB-E3FF686728D2Q33733546-F952BFC0-E4A2-493F-A996-88CC9F161102Q33745022-AD59C76C-A869-402A-847B-CB9EEBC3C7B5Q33834772-A26EEEAE-BC8D-4012-9BDB-83096C4393EDQ33908491-AADED4FA-B76C-48F9-B201-7166CCEFB9F0Q33920514-5B9B56DC-03F5-4A5A-B2C7-7DC60CE56885Q34247575-E582C1A4-AC49-41B3-8688-5C63093F617EQ34599718-74511A61-EF58-4641-BF80-1F094E0DC5E8Q34803826-58C32FEA-0272-4091-8DD8-69A6B66D58BAQ34947014-9C48668B-5EAE-42CB-90BC-4B85214C002BQ35673895-5BF53B3B-3288-4D49-9B69-6AF269A4F41FQ36009344-A5F31FC9-2896-4900-997D-C4438B77BD2FQ36103201-108801F6-5017-47CA-896D-DDAF4BE4C6A1Q36133990-CD2C7D5E-507A-4F5A-9E02-48CAE4B21202Q36247609-D30DA0D1-8345-4277-84CF-1728F73F64D6Q36266158-AC6C29E4-6A5D-411C-B756-3B0153161341Q36603032-663FC24E-3000-4517-9AB9-2D5B784FC816Q36934007-B94F4295-5666-4E88-AABC-9640B88CCD8CQ37265632-0AB10B77-8F6A-4604-8C6F-BB15B03DE3D5Q37298613-93EEAA0B-12A6-4E97-836D-F133CE6D6F24Q37423243-A766D165-B9D1-4495-8517-802529B7865EQ37424823-76B1D0D9-6DDF-49CC-BC35-F093BB6C60C9Q37490756-4566CDBE-36E8-47B3-8B1A-7398C3666BC4Q37755162-B0D9B8FB-59B8-4D85-8196-2841CD2BE19DQ37771956-1AD5E3F3-FE87-42C7-AC03-10DD97EB39F1Q37853940-CDBB9711-528E-47A1-8775-192C12B106E6Q37885186-54FDC95F-CA7D-40B9-A6E4-49CBEDB7966DQ37910273-923EB6C3-95C6-4134-A891-22E597999285Q38014851-E09D8EC3-2FC8-472D-BEA0-7245EECEA8B9Q38056917-2E0F493E-3CB1-424D-9E27-5D2DD92DB1EEQ38087391-87AB7147-C2C0-4380-8C26-64185C079008Q38096870-16D54599-C1C6-4D22-921E-77BBB26055C4
P2860
Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aptamers evolved from cultured ...... ncer cells in patient samples.
@en
type
label
Aptamers evolved from cultured ...... ncer cells in patient samples.
@en
prefLabel
Aptamers evolved from cultured ...... ncer cells in patient samples.
@en
P2093
P1433
P1476
Aptamers evolved from cultured ...... ancer cells in patient samples
@en
P2093
Weihong Tan
Zehui Charles Cao
P304
P356
10.1373/CLINCHEM.2006.083246
P407
P577
2007-04-26T00:00:00Z